Tilray (NASDAQ:TLRY) Shares Up 0.8%

Tilray Inc (NASDAQ:TLRY)’s share price shot up 0.8% on Monday . The company traded as high as $1.84 and last traded at $1.82. 5,437,135 shares changed hands during trading, a decline of 82% from the average session volume of 29,695,803 shares. The stock had previously closed at $1.80.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Alliance Global Partners boosted their target price on Tilray from $2.25 to $2.75 and gave the company a “neutral” rating in a report on Friday, April 5th. Canaccord Genuity Group cut their price target on Tilray from $4.25 to $4.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Finally, CIBC lowered their price objective on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 10th.

Tilray Price Performance

The company’s 50-day simple moving average is $2.02 and its 200-day simple moving average is $1.96. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.92 and a quick ratio of 1.18. The company has a market cap of $1.39 billion, a price-to-earnings ratio of -4.01 and a beta of 2.25.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Clear Street Markets LLC acquired a new position in Tilray during the 3rd quarter worth $25,000. Gainplan LLC acquired a new stake in shares of Tilray during the fourth quarter worth $28,000. Simplicity Wealth LLC purchased a new stake in shares of Tilray during the first quarter valued at $28,000. RPO LLC acquired a new position in shares of Tilray in the 4th quarter valued at $28,000. Finally, Wellington Wealth Strategies LLC. purchased a new position in Tilray in the 4th quarter worth about $29,000. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.